Science · 2015

The future of immune checkpoint therapy

Sharma P, Allison JP.

Show affiliations
  • Sharma PDepartment of Immunology, M.D. Anderson Cancer Center, Houston, TX, USA. Genitourinary Medical Oncology, M.D. Anderson Cancer Center, Houston, TX, USA. padsharma@mdanderson.org jallison@mdanderson.org.
  • Allison JPDepartment of Immunology, M.D. Anderson Cancer Center, Houston, TX, USA. padsharma@mdanderson.org jallison@mdanderson.org.
59 read12 want to readRigor 3.1Novelty 2.8Impact 3.3Reprod. 2.9

Most-cited papers citing this

  • MAbs · 2025 · cited by 4
  • Nature · 2026 · cited by 3
  • Curr Pharm Des · 2026 · cited by 3
  • Pharmacol Res · 2025 · cited by 2
  • Cancer Cell Int · 2026 · cited by 1

Log in to like, log, and share thoughts on this paper.

Discussion

Share your thoughts above to start a thread. Constructive feedback only — reply to and like others’ posts.

0

Omar Garcia

Rigor 1/5Novelty 5/5Impact 1/5Reprod. 5/5

Solid methods, convincing results.

0

Lena Lee

Rigor 5/5Novelty 2/5Impact 4/5Reprod. 5/5

Nice but incremental.

0

Ken Kim

Rigor 1/5Novelty 3/5Impact 4/5Reprod. 3/5

Nice but incremental.

0

Ines Mueller

Rigor 4/5Novelty 4/5Impact 5/5Reprod. 4/5

Nice but incremental.

0

Liam Garcia

Rigor 2/5Novelty 2/5Impact 4/5Reprod. 3/5

Great figures and clear story.

0

Alex Sato

Rigor 2/5Novelty 3/5Impact 5/5Reprod. 5/5

Important contribution to the field.

0

Omar Silva

Rigor 3/5Novelty 4/5Impact 4/5Reprod. 5/5

Solid methods, convincing results.

0

Noor Silva

Rigor 5/5Novelty 2/5Impact 5/5Reprod. 1/5

Important contribution to the field.

0

Ines Rossi

Rigor 5/5Novelty 2/5Impact 5/5Reprod. 1/5

Great figures and clear story.

0

Lena Kim

Rigor 2/5Novelty 5/5Impact 4/5Reprod. 2/5

Nice but incremental.

0

Omar Patel

Rigor 5/5Novelty 5/5Impact 1/5Reprod. 3/5

Interesting idea, small sample.

0

Ravi Garcia

Rigor 2/5Novelty 2/5Impact 5/5Reprod. 5/5

Replication is unclear to me.

0

Ravi Lee

Rigor 2/5Novelty 1/5Impact 5/5Reprod. 2/5

Replication is unclear to me.

0

Maya Sato

Rigor 3/5Novelty 5/5Impact 2/5Reprod. 1/5

Great figures and clear story.

0

Hugo Silva

Rigor 2/5Novelty 1/5Impact 5/5Reprod. 1/5

Nice but incremental.

0

Noor Wang

Rigor 1/5Novelty 4/5Impact 1/5Reprod. 3/5

Interesting idea, small sample.